Medicare Enrolled
Dr. Demetrios Katsikas, MD
Urology Physician · Maryville, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Katsikas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katsikas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Katsikas
Dr. Demetrios Katsikas is an urology physician in Maryville, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Katsikas performed 2,734 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Katsikas received a total of $6,178 from 47 pharmaceutical and/or device companies across 237 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Katsikas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 33% volume in IL
$6,178 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,734
Medicare services
Top 33% in IL for urology physician
Not available
Unique patients (not deduplicated)
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
507 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
373 | $80 | $318 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
337 | $58 | $249 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
210 | $49 | $127 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 171 | $133 | $700 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
155 | $8 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
145 | $7 | $38 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
143 | $48 | $125 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
135 | $170 | $721 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
119 | $78 | $295 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
49 | $194 | $736 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
49 | $2 | $21 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
48 | $10 | $101 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
48 | $114 | $426 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
48 | $37 | $96 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $115 | $368 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $22 | $102 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $101 | $684 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $25 | $436 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $132 | $487 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $62 | $224 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
14 | $80 | $265 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $80 | $1,122 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
11 | $321 | $1,214 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
8.9% medium
90.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,178
Total received (2018-2024)
Avg $883/year across 7 years
Top 28% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
237
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$858
2023
$1,578
2022
$964
2021
$736
2020
$245
2019
$876
2018
$921
Payments by company (2024)
Sumitomo Pharma America, Inc.
$186
UROGEN PHARMA, INC.
$182
ACCORD HEALTHCARE, INC.
$108
Myriad Genetic Laboratories, Inc.
$78
Janssen Biotech, Inc.
$73
Bayer Healthcare Pharmaceuticals Inc.
$51
PROGENICS PHARMACEUTICALS, INC.
$41
Astellas Pharma US Inc
$35
Telix Pharmaceuticals
$30
Dendreon Pharmaceuticals LLC
$22
VERTEX PHARMACEUTICALS INCORPORATED
$21
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
SRS Medical Systems, Inc.
$14
Top 3 companies account for 55.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$779
Myriad Genetic Laboratories, Inc.
$776
Janssen Biotech, Inc.
$515
NeoTract Inc.
$398
ACCORD HEALTHCARE, INC.
$330
PFIZER INC.
$279
Sumitomo Pharma America, Inc.
$257
KARL STORZ Endoscopy-America
$200
UROGEN PHARMA, INC.
$182
Progenics Pharmaceuticals, Inc.
$178
Boston Scientific Corporation
$166
Myovant Sciences Inc.
$162
Teleflex LLC
$160
Rochester Medical Corporation
$154
Galderma Laboratories, L.P.
$135
Bayer Healthcare Pharmaceuticals Inc.
$111
BOSTON SCIENTIFIC CORPORATION
$107
Antares Pharma, Inc.
$104
Endo Pharmaceuticals Inc.
$100
Janssen Products, LP
$99
Novartis Pharmaceuticals Corporation
$87
Avadel Specialty Pharmaceuticals, LLC
$82
TOLMAR Pharmaceuticals, Inc.
$66
C. R. Bard, Inc. & Subsidiaries
$65
Travere Therapeutics, Inc.
$58
Telix Pharmaceuticals
$53
Tolmar, Inc.
$52
UROVANT SCIENCES INC
$44
UroGen Pharma, Inc.
$43
PROGENICS PHARMACEUTICALS, INC.
$41
Blue Earth Diagnostics Limited
$41
Bayer HealthCare Pharmaceuticals Inc.
$36
Clarus Therapeutics Inc.
$34
PROCEPT BioRobotics Corporation
$34
Ferring Pharmaceuticals Inc.
$29
Amgen Inc.
$27
AbbVie, Inc.
$27
Janssen Pharmaceuticals, Inc
$27
Dendreon Pharmaceuticals LLC
$22
VERTEX PHARMACEUTICALS INCORPORATED
$21
Medtronic USA, Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
SRS Medical Systems, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Allergan Inc.
$13
Laborie Medical Technologies Corp.
$12
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMBICOR · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BOTOX COSMETIC · Bard Urinary Drainage Bag · CAMCEVI · CT3000 Pro Base Unit · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL - KIDNEY STONE DISEASE · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · LITHOVUE · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SEGLENTIS · SPACEOAR · TOVIAZ · TRADE PROMO: SPIES FLEXC · Thiola · UROLIFT · US DEFL · UroLift · UroLift System · XARELTO · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
71
County median income
$74,800
Nearest hospital to ZIP centroid (approximate)
ANDERSON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Katsikas is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Katsikas experienced with automated urinalysis?
Based on Medicare claims data, Dr. Katsikas performed 507 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Katsikas receive payments from pharmaceutical companies?
Yes. Dr. Katsikas received a total of $6,178 from 47 companies across 237 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katsikas's costs compare to other urology physicians in Maryville?
Dr. Katsikas's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katsikas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Maryville
Browse urology physicians in Maryville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology